Flex Pharma, Inc. (52) | Purchase Agreements (2)
- Securities Purchase Agreement dated April 22, 2022 (Filed With SEC on April 22, 2022)
- Asset Purchase Agreement dated July 23, 2019 by and among Salarius Pharmaceuticals, Inc., Flex Innovation Group LLC and Cliff-Cartwright Corporation (Filed With SEC on July 24, 2019)